Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Skawina

6 clinical trials in Skawina, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Skawina at a glance
6
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Skawina

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Human Glucagon-Like Peptide-2 Analogue Linked To A Human Immunoglobulin Fc Fragment
  • Sponsor:Hanmi Pharm. Co. Ltd.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S

Short-bowel syndrome

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apraglutide
  • Sponsor:VectivBio AG

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Skawina

What the registry says about research in the country

01 Gastrointestinal Research

Clinical trials focusing on evaluating novel treatments for Short Bowel Syndrome (SBS), a complex intestinal disorder requiring specialized therapeutic approaches.

  • Treatment Safety Studies
  • Long-term Efficacy Assessment
  • Patient Quality of Life

Current research examines innovative therapeutic agents including apraglutide and glepaglutide for managing SBS symptoms and complications.

02 Digestive System Disorders

Ongoing investigations into treatments for patients with intestinal failure associated with Short Bowel Syndrome, focusing on therapeutic tolerance and long-term outcomes.

  • Treatment Optimization
  • Safety Monitoring
  • Clinical Response Assessment

Multiple parallel studies are evaluating different therapeutic approaches to enhance patient care and treatment effectiveness.

03 Therapeutic Development

Comprehensive research program investigating the safety profiles of new peptide therapeutics for gastrointestinal disorders.

  • Drug Safety Evaluation
  • Treatment Tolerability
  • Long-term Effectiveness

These studies aim to establish robust safety data for novel treatments in the management of intestinal disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.